Labor Market Pulse · Life Sciences · September 2026
Life Sciences Labor Market Report: Bay City, MI MSA — September 2026
Bay City's shrinking labor pool pushes clinical pay above national rates.
Bay City's advertised CRA pay has reached $98,354 against a $90,956 national median, even as the metro's labor force keeps contracting and unemployment holds near 4.2%.
Free archive edition. Published by WageScape as sent to subscribers; data as of September 2026.
Key indicators
- Bay City CRA advertised pay: $98,354 — vs $90,956 national median, both trending up
- Bay City unemployment rate: 4.2% — vs Michigan state average 5.0% in August
- Bay City civilian labor force: 46,400 — June 2026, reflecting ongoing contraction
- Michigan biotech/pharma avg hourly pay: $37.98 — Range $23.85–$47.29, below coastal biotech hubs
Key takeaways
Bay City's CRA pay premium outpaces the national trend.
Advertised median pay for Clinical Research Associates in Bay City has risen to $98,354, above the $90,956 national median, even as both move upward. A small, shrinking metro labor pool appears to be forcing employers to bid above national rates to secure clinical talent.
Workforce contraction, not demand collapse, is the real constraint.
Bay City's civilian labor force has fallen even as unemployment holds near 4.2%, consistent with Michigan's broader 0.5% monthly labor force decline. Headcount plans built on local hiring assumptions may need wider geographic search radii or remote/hybrid clinical and regulatory roles to compensate.
Michigan's biomanufacturing apprenticeship push signals a longer-term fix, not a near-term one.
The state's proposed $2.06 million BioWorkforce Apprenticeship Program targets non-degreed talent for GMP, cleanroom, and aseptic processing roles, but 12-month paid apprenticeships won't close 2026 staffing gaps. Quality and manufacturing leaders should treat this as a multi-year pipeline investment rather than a lever for current vacancies.
Statewide pay compression keeps Michigan behind coastal biotech hubs.
Average biotech/pharma hourly pay in Michigan sits at $37.98, well below rates typical of Boston or San Diego markets, which may hinder efforts to recruit experienced regulatory or CMC leaders into the state. Compensation benchmarking should account for this gap when competing for talent with multi-state mobility.
Median advertised pay by role — Bay City, MI MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist * | $95,062 | $133,986 | $152,750 | Significant increase | $131,354 |
| Clinical Research Associate * | $71,571 | $98,354 | $104,246 | Significant increase | $90,956 |
| Lab Technician * | $37,668 | $44,932 | $46,933 | Stable | $47,402 |
| Regulatory Affairs Specialist * | $68,607 | $95,340 | $114,031 | Significant decline | $104,000 |
| Clinical Data Manager * | $97,759 | $128,800 | $150,000 | Significant decline | $123,031 |
| Biostatistician * | $111,515 | $131,971 | $156,868 | Stable | $133,322 |
| Validation Engineer * | $77,591 | $100,880 | $110,300 | Stable | $108,377 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Bay City's unemployment rate held near 4.2% in September while the region's labor force kept shrinking — civilian labor force stood at 46,400 as of June, down from prior readings — leaving fewer workers available even as manufacturing employment stayed flat at 4.8 thousand jobs in July. Statewide, Michigan's workforce contraction (down 0.5% over the month in August against a rising national labor force) compounds the local supply problem, meaning Bay City life sciences employers compete for a pool that is both small and not growing.
What it means
Shrinking labor supply in a metro already thin on biomanufacturing and quality talent raises the cost and timeline risk of building out regulatory, CMC, or validation headcount locally, reinforcing the statewide pattern where talent constraints — not capital or equipment — are steering companies toward CRO/CDMO partnerships rather than in-house expansion. Clinical Research Associate advertised pay in the metro has climbed to a $98,354 median, running meaningfully ahead of the $90,956 national figure, signaling that even mid-tier clinical roles are drawing premium bids in a market too small to absorb demand spikes. Organizations should evaluate whether critical-path hires — CRA, QC/QA, regulatory affairs — are better secured through outsourced partners or contract staffing given how quickly local advertised pay can outrun national benchmarks.
Looking ahead
Worth watching: Whether Bay City's unemployment rate stabilizes near 4.2% or drifts toward the state's 5.0% average will indicate if local labor supply tightening is easing or deepening heading into Q4 hiring cycles.
Emerging pressure point: Continued CRA pay acceleration locally could spread to adjacent clinical operations and regulatory roles if the pattern reflects broader scarcity rather than a single-role anomaly. Watch whether Q4 postings show pay increases spreading beyond clinical research titles.
Potential inflection point: Progress on Michigan's BioWorkforce Apprenticeship funding request could signal state-level commitment to addressing manufacturing talent gaps. A funding decision in coming months would be an early signal of whether public investment meaningfully expands the regional pipeline.
Early indicator: National biopharma layoffs (BioMarin, Bristol Myers) alongside 64% of firms still actively recruiting suggests released talent may surface in secondary markets like Bay City. Monitor whether out-of-state candidates with CDMO or clinical experience begin appearing in local applicant pools.
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.